Retraction
RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo
Paper Information
Record ID:
2866
Author(s):
Journal:
Publication Date:
January 16, 2016
Retraction Date:
February 02, 2016
(9.8 years years ago)
Subjects:
Institutions:
Countries:
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (6)
6
Total Citations5
Post-Retraction(83.3%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
3
After 2+ years
2676
Days since retraction (latest)
Paper citing RGD peptide-pegylated PLLA nanoparticles containin...
Unknown Authors
Unknown Journal
Published: Unknown
Tumor-targeted astaxanthin nanoparticles for therapeutic application in vitro
Wei Xie, S H Tan, Xiyun Ren et al. (9 authors)
Colloids and Interface Science Communications
Open Access
Published: Jun 2023
2 citations
2 citations
2676 days after retraction
Paper citing RGD peptide-pegylated PLLA nanoparticles containin...
Unknown Authors
Unknown Journal
Published: Oct 2019
1337 days after retraction
Paper citing RGD peptide-pegylated PLLA nanoparticles containin...
Unknown Authors
Unknown Journal
Published: Apr 2018
804 days after retraction
Paper citing RGD peptide-pegylated PLLA nanoparticles containin...
Unknown Authors
Unknown Journal
Published: Feb 2017
386 days after retraction
131I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomas
Gao Jingmei, Lei Fang, Danyang Sun et al. (9 authors)
Brain Research
Published: Dec 2016
12 citations
12 citations
323 days after retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
9.8 years
Open Access:
Yes
Last Checked:
Never